IMUN
Immune Therapeutics Inc

257
Mkt Cap
$7,871.00
Volume
2.00
52W High
$0.01
52W Low
$0.0001
Price
$0.0601
IMUN Fundamentals
Prev Close
$0.07
Open
$0.0651
50D MA
$0.0001
Beta
-12.55
Avg. Volume
71.05
Loading...
Loading...
Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immune Therapeutics Inc?
What is the 52-week high for Immune Therapeutics Inc?
What is the 52-week low for Immune Therapeutics Inc?
What is Immune Therapeutics Inc stock price today?
What was Immune Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Immune Therapeutics Inc?

Latest IMUN News

View
No IMUN news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.